Marie L. Woolley - Concepedia

Author

Marie L. Woolley

Also Known As

M. L. Woolley, M.L Woolley, M.L. Woolley, MARIE L WOOLLEY, Marie L Woolley, Marie L. Woolley, Marie Woolley, Trishna Uttamlal

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)Roche (Switzerland)GlaxoSmithKline (Italy)University of Bradford GlaxoSmithKline (Netherlands)

About

Marie L. Woolley is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.7K
2	Social Sciences	12	14	1.5K
3	Health Sciences	1	1	56
4	Behavioral Sciences	1	1	12
5	Biochemistry	1	1	74

Marie L. Woolley

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
GSK189254, a Novel H3 Receptor Antagonist That Binds to Histamine H3 Receptors in Alzheimer’s Disease Brain and Improves Cognitive Performance in Preclinical Models Andrew D. Medhurst, A.R. Atkins, I.J.M. Beresford, Journal of Pharmacology and Experimental Therapeutics	2007	300
A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze Marie L. Woolley, Jane Bentley, Andrew J. Sleight, Neuropharmacology Synaptic PlasticityCognitive ScienceNeurobiological MechanismSpatial LearningBehavioral Neuroscience	2001	200
Activity of 2,3-benzodiazepines at Native Rat and Recombinant Human Glutamate Receptors In Vitro : Stereospecificity and Selectivity Profiles David Bleakman, Barbara A. Ballyk, Darryle D. Schoepp, Neuropharmacology NeurophysiologyMedicineNative RatNeurotransmitterFunctional Selectivity	1996	193
5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation—an effect sensitive to NMDA receptor antagonism Madeleine V. King, Andrew J. Sleight, Marie L. Woolley, Neuropharmacology Synaptic PlasticityNovel Object DiscriminationNmda Receptor AntagonismBrain FunctionFunctional Selectivity	2004	192
The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity Marie L. Woolley, Darrel J. Pemberton, Simon T. Bate, Psychopharmacology PsychiatryFunctional SelectivityMedicinePsychotropic MedicationPsychopharmacology	2007	187
Age-dependent cognitive decline and amygdala pathology in α-synuclein transgenic mice Christian Freichel, Manuela Neumann, Theresa M. Ballard, Neurobiology of Aging Neurodegenerative DiseasesNeurobiology Of DiseaseSynaptic NeuroscienceAmygdala PathologyDegenerative Pathology	2006	170
Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro�04-6790 Marie L. Woolley, C.A. Marsden, Andrew J. Sleight, Psychopharmacology Cholinergic-induced DeficitMedicineRodent ModelMemoryNeuropharmacology	2003	123
The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison Theresa M. Ballard, Marie L. Woolley, Eric Prinssen, Psychopharmacology Experimental PsychopathologyNeuropsychologyRodent TestsStress HormonePsychiatry	2005	111
Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice Marie L. Woolley, Helen J. Carter, Jane Gartlon, European Journal of Pharmacology Functional SelectivityMedicinePhysiologyMechanism Of ActionAmphetamine-induced Activity	2008	98
A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats Samantha L. McLean, Jonathan P. Beck, Marie L. Woolley, Behavioural Brain Research Psychoactive DrugPsychiatryBehavioral NeuroscienceMedicinePsychotropic Medication	2008	88

Page 1